
Central to the discussion was a new study that is investigating the effects of 1 mg of MenaQ7 Vitamin K2 as MK-7 from Gnosis by Lesaffre versus placebo on arterial stiffness and the occurrence of cardiovascular events in end-stage renal disease patients undergoing peritoneal dialysis over the course of 1.5 years.



























